Influence of humoral immunity on leukotriene B4 production by neutrophils in response to Trichomonas vaginalis stimulation
暂无分享,去创建一个
[1] M. Shaio,et al. Leucotriene B4 levels in the vaginal discharges from cases of trichomoniasis. , 1995, Annals of tropical medicine and parasitology.
[2] M. Shaio,et al. Monocyte-derived interleukin-8 involved in the recruitment of neutrophils induced by Trichomonas vaginalis infection. , 1994, The Journal of infectious diseases.
[3] S. McColl,et al. Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. , 1993, Journal of immunology.
[4] M. Seedat,et al. Vaginal Infections in Diabetic Women: Is Empiric Antifungal Therapy Appropriate? , 1993, Sexually transmitted diseases.
[5] Shaio Men-Fang,et al. Killing of Trichomonas vaginalis by complement-mediated lysis is not associated with the presence of Trichomonas vaginalis virus , 1993 .
[6] C. S. Lee,et al. A novel neutrophil-activating factor released by Trichomonas vaginalis , 1992, Infection and immunity.
[7] P. Piot,et al. HIV and other sexually transmitted diseases among female prostitutes in Kinshasa. , 1991, AIDS.
[8] C. S. Lee,et al. The role of immunoglobulin and complement in enhancing the respiratory burst of neutrophils against Trichomonas vaginalis , 1991, Parasite immunology.
[9] N. Matthews,et al. Zymosan-induced leukotriene B4 generation by human neutrophils is augmented by rhTNF-alpha but not chemotactic peptide. , 1990, Immunology.
[10] C V Jongeneel,et al. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.
[11] S. Djurić,et al. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions. , 1989, Prostaglandins.
[12] M. Shaio,et al. Immunoglobulin M-dependent classical complement pathway activation in killing of Pentatrichomonas hominis , 1989, Infection and immunity.
[13] A. Kay,et al. Leukotriene B4 generation by human neutrophils following IgG-dependent stimulation. , 1987, Immunology.
[14] K. Matsushima,et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.
[15] N. Topley,et al. Activation of human polymorphonuclear leucocytes by particulate zymosan is related to both its major carbohydrate components: glucan and mannan. , 1986, Immunology.
[16] R. Lewis,et al. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. , 1985, Journal of immunology.
[17] C. Haslett,et al. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. , 1985, The American journal of pathology.
[18] J. Wallin,et al. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. , 1983, The Journal of clinical endocrinology and metabolism.
[19] B. Samuelsson. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.
[20] K. Su,et al. Antibody to Trichomonas vaginalis in human cervicovaginal secretions , 1982, Infection and immunity.
[21] A. Sher,et al. Activation of the alternative complement pathway by Trichomonas vaginalis , 1981, Infection and immunity.
[22] M. Shaio,et al. A method for the isolation of Trichomonas hominis in axenic culture. , 1981, Annals of tropical medicine and parasitology.
[23] F. Conde,et al. Human immunoglobulin M purification by affinity chromatography on protein A--Sepharose. , 1981, Journal of biochemical and biophysical methods.
[24] G. Mandell,et al. Trichomonacidal activity of human polymorphonuclear neutrophils: killing by disruption and fragmentation. , 1980, The Journal of infectious diseases.
[25] M. A. Bray,et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.
[26] A. Fouts,et al. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. , 1980, The Journal of infectious diseases.
[27] R. Ulevitch,et al. The effects of bacterial endotoxins on host mediation systems. A review. , 1978, The American journal of pathology.
[28] R. Catterall,et al. Antitrichomonal antibody in the vaginal secretions of women infected with T. vaginalis. , 1975, The British journal of venereal diseases.
[29] A Mowat,et al. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. , 1971, The New England journal of medicine.
[30] Shaio Men-Fang,et al. Killing of Trichomonas vaginalis by complement-mediated lysis is not associated with the presence of Trichomonas vaginalis virus. , 1993, International journal for parasitology.
[31] D. Yang,et al. Multiple actions of the leukotriene B4 receptor antagonist SC-41930. , 1992, The Journal of pharmacology and experimental therapeutics.
[32] J. Ackers. Immunologic Aspects of Human Trichomoniasis , 1990 .
[33] P. Lachmann,et al. Specificity of membrane complement receptor type three (CR3) for beta-glucans. , 1987, Complement.
[34] B. Mach,et al. Expression of human IL 1 alpha and beta messenger RNAs and IL 1 activity in human peripheral blood mononuclear cells. , 1987, The Journal of molecular and cellular immunology : JMCI.
[35] T. W. Holbrook,et al. Trichomonas vaginalis: alternative pathway activation of complement. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[36] L S Diamond,et al. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. , 1978, Transactions of the Royal Society of Tropical Medicine and Hygiene.